Home > Insider Trading > Filing (0000950170-25-075403)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501796	Aura Biosciences Inc.	AURA	Biological Products, (No Disgnostic Substances) (2836)	320271970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1750132	S Anthony Gibney	C/O Aura Biosciences, Inc. 80 Guest Street Boston MA 02135	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-16	50,000	$4.90	58,452	No	4	P	Direct
Common Stock	Disposition	2025-05-16	1,519	$5.15	56,933	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2025-05-16	12,500	$0.00	12,500	$4.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,500	2025-05-16	2030-05-16	No	4	P	Direct

Footnotes

On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.
The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.